These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment. Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973 [TBL] [Abstract][Full Text] [Related]
18. Conversion to sirolimus in posttransplant renal neoplasms. Lopez V; Gutierrez C; Cabello M; Burgos D; Sola E; Gonzalez-Molina M Transplant Proc; 2007 Sep; 39(7):2264-6. PubMed ID: 17889158 [TBL] [Abstract][Full Text] [Related]
19. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus. Oberbauer R Transplantation; 2009 Apr; 87(8 Suppl):S7-10. PubMed ID: 19384186 [TBL] [Abstract][Full Text] [Related]
20. The effect of sirolimus in the development of chronic allograft nephropathy. Gürkan A; Kaçar S; Erdoğdu U; Varilsüha C; Kandemir G; Karaca C; Akman F Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]